A Phase 1 Trial of Durvalumab in Combination with Bacillus Calmette-Guerin (BCG) or External Beam Radiation Therapy in Patients with BCG-unresponsive Non-muscle-Invasive Bladder Cancer: The Hoosier Cancer Research Network GU16-243 ADAPT-BLADDER Study

Author:

Hahn Noah M.,O'Donnell Michael A.,Efstathiou Jason A.,Zahurak Marianna,Rosner Gary L.,Smith Jeff,Kates Max R.,Bivalacqua Trinity J.,Tran Phuoc T.,Song Daniel Y.,Baras Alex S.,Matoso Andres,Choi Woonyoung,Smith Kellie N.,Pardoll Drew M.,Marchionni Luigi,McGuire Bridget,Grace Phelan Mary,Johnson Burles A.,O'Neal Tanya,McConkey David J.,Rose Tracy L.,Bjurlin Marc,Lim Emerson A.,Drake Charles G.,McKiernan James M.,Deutsch Israel,Anderson Christopher B.,Lamm Donald L.,Geynisman Daniel M.,Plimack Elizabeth R.,Hallman Mark A.,Horwitz Eric M.,Al-Saleem Essel,Chen David Y.T.,Greenberg Richard E.,Kutikov Alexander,Guo Gordon,Masterson Timothy A.,Adra Nabil,Kaimakliotis Hristos Z.

Publisher

Elsevier BV

Subject

Urology

Reference34 articles.

1. Results of a randomised controlled trial comparing intravesical chemohyperthermia with mitomycin C versus bacillus Calmette-Guérin for adjuvant treatment of patients with intermediate- and high-risk non-muscle-invasive bladder cancer;Arends;Eur Urol,2016

2. EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2016;Babjuk;Eur Urol,2017

3. Treatment of non-metastatic muscle-invasive bladder cancer: AUA/ASCO/ASTRO/SUO guideline;Chang;J Urol,2017

4. National Cancer Institute. Surveillance, Epidemiology, and End Results (SEER) Program SEER*Stat Database: Incidence - SEER Research Data, 9 Registries, Nov 2020 Sub (1975–2018) - Linked To County Attributes - Time Dependent (1990–2018) Incom/Rurality, 1969–2019 Counties. April 2021. www.seer.cancer.gov2021

5. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Sung;CA Cancer J Clin,2021

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3